Issue 2026-11-11 · Industry · 研究 · 安全 · 应用
Study Finds Drug Ads Can Influence AI Treatment Recommendations

A Mount Sinai study in The Lancet Digital Health tested 12 AI models from Google, OpenAI, Anthropic and others, finding a labeled drug ad before a clinical case shifted treatment choices. Across 33 scenarios, the advertised drug was chosen in 47.6% of responses with an ad versus 35% without; in four cases the rate moved from 0% to 100%. Authors warn answers can look medically sound while preferences are swayed.
Read original ↗Topics:Icahn School of Medicine at Mount SinaiGoogleOpenAIAnthropicMahmud OmarThe Lancet Digital Health
- Gemini 4 Carbon tops MathArena at 15x GPT-6.1 Sol cost
- Advocacy groups sue five AI giants to halt new model development
- Vatican says Silicon Valley has no monopoly on AI's future
- Report: closed models dominate price-performance frontier as open share hits low
- US Tech Giants' Hidden AI Debt Jumps 90% to $3.2T in Six Months